- Healthy interest coverage ratio of 19.1x
- High gross margin of 75.9%
- Lower volatility than the market (beta 0.24)
BioMarin Pharmaceutical Inc. stock price ended at $55.12 on Tuesday, after losing 0.95%
(Updated on Jun 16, 2026)
The BioMarin Pharmaceutical Inc. stock price fell by -0.95% on the last day (Tuesday, 16th Jun 2026) from $55.65 to $55.12. During the last trading day the stock fluctuated 2.23% from a day low at $54.61 to a day high of $55.83. The price has been going up and down for this period, and there has been a 3.38% gain for the last 2 weeks. Volume has increased on the last day by 37 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $79.78 million.
The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect BioMarin Pharmaceutical Inc. stock with a 90% probability to be traded between $48.69 and $57.01 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
BMRN Signals & Forecast
The BioMarin Pharmaceutical Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $56.13. On a fall, the stock will find some support from the long-term average at approximately $54.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen -4.82%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock
BioMarin Pharmaceutical Inc. finds support from accumulated volume at $55.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.22 between high and low, or 2.23%. For the last week, the stock has had daily average volatility of 2.52%.
Our recommended stop-loss: $52.76 (-4.29%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 5 days ago.)
Trading Expectations (BMRN) For The Upcoming Trading Day Of Wednesday 17th
For the upcoming trading day on Wednesday, 17th we expect BioMarin Pharmaceutical Inc. to open at $55.19, and during the day (based on 14 day Average True Range), to move between $54.28 and $55.96, which gives a possible trading interval of +/-$1.69 (+/-3.11%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 3.11% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $55.03 (0.16%) than the resistance at $55.46 (0.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is BioMarin Pharmaceutical Inc. stock A Buy?
BioMarin Pharmaceutical Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.318
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 17, 2026 - $55.19 ( 0.121%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BMRN Performance
Trading levels for BMRN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 56.41 | 2.33% |
| R2 | 55.94 | 1.49% |
| R1 | 55.65 | 0.97% |
| Price | 55.12 | |
| S1 | 54.72 | -0.725% |
| S2 | 54.43 | -1.25% |
| S3 | 53.97 | -2.09% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 57.29 | 3.94% |
| R2 | 56.05 | 1.69% |
| R1 | 55.46 | 0.617% |
| Price | 55.12 | |
| S1 | 55.03 | -0.163% |
| S2 | 54.10 | -1.85% |
| S3 | 53.24 | -3.41% |
FAQ
Click here for our free guide on how to buy BioMarin Pharmaceutical Inc. Stock.
Buy BMRN